Page last updated: 2024-10-17

lactic acid and Muscular Dystrophy, Facioscapulohumeral

lactic acid has been researched along with Muscular Dystrophy, Facioscapulohumeral in 1 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Muscular Dystrophy, Facioscapulohumeral: An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lovadi, E1
Csereklyei, M1
Merkli, H1
FüLöp, K1
Sebők, Á1
Karcagi, V1
Komoly, S1
Pál, E1

Other Studies

1 other study available for lactic acid and Muscular Dystrophy, Facioscapulohumeral

ArticleYear
Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases.
    Muscle & nerve, 2017, Volume: 55, Issue:4

    Topics: Adult; Aged; Creatine Kinase; Disease Progression; DNA, Mitochondrial; Enzyme-Linked Immunosorbent A

2017